Roger A’Hern

31.8k citations
284 papers · 25.9k · 5 hit papers · h-index 81

Impact in

    • Breast Cancer Treatment Studies
    • Cancer Genomics and Diagnostics
  • Oncology top 0.1%
    • HER2/EGFR in Cancer Research
    • PARP inhibition in cancer therapy

Papers in

    • HER2/EGFR in Cancer Research 14
    • Cancer survivorship and care 13
    • Cancer Treatment and Pharmacology 10
    • Breast Cancer Treatment Studies 43

Roger A’Hern

282 papers receiving 24.7k citations

Roger A’Hern's Hit Papers

DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer 2015 · 1.8k citations
1.8k0+5+11Years since publication50010001.5k

Peers

Roger A’Hern
Comparison fields: 5 of 170
  • Cancer Research 5.8k
  • Oncology 9.1k
  • Otorhinolaryngology 1.2k
  • Pulmonary and Respiratory Medicine 5.7k
  • Reproductive Medicine 1.4k
Replace George Fountzilas with:
George Fountzilas Greece
Lynn A. G. Ries United States
Phyllis A. Wingo United States
Harm van Tinteren Netherlands
Hyman Bernard Muss United States
Gemma Gatta Italy
John Daniel Hainsworth United States
Valter Torri Italy
Sharon Hermes Giordano United States
Otto J. Visser Netherlands
Roger A’Hern relative to George Fountzilas Greece George Fountzilas's profile →
Citations per field
00.5×1.5×
George Fountzilas · 1×
Citations per year

Countries citing papers authored by Roger A’Hern

Since Specialization
Citations

This map shows the geographic impact of Roger A’Hern's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roger A’Hern with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roger A’Hern more than expected).

Fields of papers citing papers by Roger A’Hern

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roger A’Hern. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roger A’Hern. The network helps show where Roger A’Hern may publish in the future.

Co-authors

The 25 scholars most cited alongside Roger A’Hern, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Roger A’Hern Line = papers co-authored together Roger A’Hern links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 284 papers — load more, or switch the sort, to bring in the rest.

#Work
1
DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer
Hit paper breakdown →
20151813
2
Assessment of Ki67 in Breast Cancer: Recommendations from the International Ki67 in Breast Cancer Working Group
Hit paper breakdown →
20111684
3
Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial
Hit paper breakdown →
20111375
4
Poly(ADP)-Ribose Polymerase Inhibition: Frequent Durable Responses in BRCA Carrier Ovarian Cancer Correlating With Platinum-Free Interval
Hit paper breakdown →
2010849
5 2007557
6 2008527
7
Selective Inhibition of CYP17 With Abiraterone Acetate Is Highly Active in the Treatment of Castration-Resistant Prostate Cancer
Hit paper breakdown →
2009499
8 2009474
9 2004355
10 2009353
11 2001341
12 2005319
13 2019306
14 1997302
15 2012300
16 2000299
17 2000289
18 2010289
19 1990276
20 2004275

About Roger A’Hern

Roger A’Hern is a scholar working on Oncology, Cancer Research, Reproductive Medicine, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine, having authored 284 papers that have together received 25.9k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (43 papers), Estrogen and related hormone effects (24 papers), Ovarian cancer diagnosis and treatment (21 papers), HER2/EGFR in Cancer Research (14 papers), Cancer survivorship and care (13 papers), Head and Neck Cancer Studies (12 papers), Breast Lesions and Carcinomas (11 papers) and Cancer Treatment and Pharmacology (10 papers). The work is most often cited by research in Cancer Research (5.8k citations), Oncology (9.1k citations), Otorhinolaryngology (1.2k citations), Pulmonary and Respiratory Medicine (5.7k citations) and Reproductive Medicine (1.4k citations). Roger A’Hern has collaborated with scholars based in United Kingdom, United States and Canada. Frequent co-authors include Mitch Dowsett, Martin Eric Gore, Janine Salter, Janet Rea Hardy, Ian E. Smith, Cyril Fisher, Patrick Charles Stone, Kevin Joseph Harrington, Simone I. DETRE and Jorge Sergio Reis-Filho. Their work appears in journals such as British Journal of Cancer, Journal of Clinical Oncology, Annals of Oncology, European Journal of Cancer and The Lancet.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact